Scientist
Current1. Collaborate with CRO for the PK/safety study, which supports the IND application for iDose in US clinical trial.2. Establish bench top in vitro assay for in house compound analysis.
Please complete the CAPTCHA to continue
@glaukos.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Jia-Ying John Y. is listed as Self-motivated scientist with extensive hand-on in-vivo experience at Glaukos Corporation, a with 551 employees, based in Irvine, California, United States. AeroLeads shows a work email signal at glaukos.com and a matched LinkedIn profile for Jia-Ying John Y..
Jia-Ying John Y. previously worked as Scientist at Glaukos Corporation and Scientist at Allergan. Jia-Ying John Y. holds Ph.D, Experimental Pathology And Laboratory Medicine from Uc Irvine.
This section adds company-level context without repeating Jia-Ying John Y.'s masked contact details.
AeroLeads found 1 current-domain work email signal for Jia-Ying John Y.. Compare company email patterns before reaching out.
Scientist with proficiency in mitochondrial function assessment, electrophysiology, behavioral, noninvasive imaging and biochemical endpoints to assess compound activity, target selection and lead identification. Experienced in small rodent(mouse and rat), rabbit and non-human primate model development and implementation, animal colony management, chemokine/cytokine quantification(multiplex and ELISA), cell culture, and library screening.
Listed skills include Screening, Cell Biology, In Vivo, Cap, and 121 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
1. Collaborate with CRO for the PK/safety study, which supports the IND application for iDose in US clinical trial.2. Establish bench top in vitro assay for in house compound analysis.
Irvine, Ca
1. Non-invasive electroretinography(ERG) and ocular imaging investigation of retinal degeneration in knockout mice model supporting target selection.2. Development of a retinal degeneration model for compound assessment through electrophysiological endpoints (ERG and visual evoked potential (VEP))3. In vivo compound specificity and neural transmission pathway evaluation utilizing receptor null animals.
Irvine
1. Conducted mouse behavior studies supporting in-vivo compound screening of neuro-enhancement compounds.2. Established and refine electrophysiology endpoints allowing isolation of inner retina functional activity (scotopic threshold response (STR)). 3. Conducted pharmacokinetic studies, dosing and tissue collection.4. High-throughput compound screening.
Irvine, Ca
1. Investigate insulin-induced Akt1/2 translocation to mitochondria in wild type, Akt1/2 knockout and diabetic myocardium, and it's effect on mitochondrial function. 2. Investigate gene expression profile and mitochondrial abundance changes in mouse embryonic stem cell (ESC) and induced pluripotent stem cell (iPSC).
Irvine, Ca
1. Discover the novel signaling pathway of insulin induced-Akt translocation to mitochondria in myocardium, and its implication on mitochondrial function in insulin deficient or resistant diabetic myocardium.2. Investigate the phenotypes from cbl-associated protein (CAP) knocked out mice, including glucose tolerance test, insulin tolerance test and histological study. 3. Build a myocardium-specific, tet on/off controlled heat shock protein 60 (hsp60) overexpression mouse line..Publications:1. Yang JY, Deng W, Chen Y, Fan W, Baldwin KM, Jope RS, Wallace DC, Wang PH. Impaired translocation and activation of mitochondrial Akt1 mitigated mitochondrial oxidative phosphorylation Complex V activity in diabetic myocardium. J Mol Cell Cardiol. 2013 Jun;59: p167-175.2. Yang JY, Yeh HY, Lin K and Wang PH. Insulin stimulates Akt translocation to mitochondria: implications on dysregulation of mitochondrial oxidative phosphorylation in diabetic myocardium. J Mol Cell Cardiol. 2009 Jun;46(6):p919-926.3. Lai HC, Liu TJ, Ting CT, Yang JY, Huang L, Wallace D, Kaiser P and Wang PH. Regulation of IGF-1 receptor signaling in diabetic cardiac muscle: dysregulation of cytosolic and mitochondria HSP60. Am J Physiol Endocrinol Metab. 2007 Jan;292(1):E292-297.4. Chen HS, Jia J, Su HF, Lin HD, Chenc JW, Lin SJ, Yang JY, Lai HC, Mestril R and Wang PH. Downregulation of the constitutively expressed Hsc70 in diabetic myocardium is mediated by insulin deficiency. J Endocrinol. 2006 Aug;190(2):433-440.
Lecture in Biochemistry Lab. Also held a section for student who had questions in Biochemistry lecture.
Irvine
1. In vitro photodynamic injury model (retinal pigment epithelial cell and choroidal endothelial cell) to assess compound efficacy and in vitro treatment condition. 2. Assess the retinal and choroidal blood flow change in photodynamic injured rabbit and monkey.3. Elecrtrophysiological(ERG) assessment of neuroprotective compounds on acute-elevation of intra-ocular pressure (IOP) in rabbit.
Taipei City, Taiwan
Investigated the monoclonality in NK/T cell in sinonasal lymphoma- determine the length polymorphism in T cell receptor rearrangement (TCR) and in killer immunoglobulin-like receptor (KIR) V-J junction region.Publications:1. Lin CW, Yang JY, Chuang YC, Chen YH, Albitar M, Hsu SM. Presence of restricted killer immunoglobulin-like receptor repertoire and monoclonal T-cell receptor gamma rearrangement as evidence of mixed NK/T-cell differentiation in a subset of sinonasal lymphomas. Lab Invest. 2003 Jan;83(1):55-64.2. Lin CW, Lee WH, Chang CL, Yang JY, Hsu SM. Restricted killer cell immunoglobulin-like receptor repertoire without T-cell receptor gamma rearrangement supports a true natural killer-cell lineage in a subset of sinonasal lymphomas. Am J Pathol. 2001 Nov;159(5):1671-9.
Taipei City, Taiwan
Investigated rat primary microglia cell in response to cytokines and beta-amyloid peptides, which plays an important role in the pathogenesis of Alzheimer's disease.
Executed Anti-smuggling mission along the coastline of Taoyuan county.
Investigated the relationship between apo-E genotypes and homocystein concentration in serum from hypertension patients.Skills: HPLC (reverse phase), apo-E genotyping, RFLP
Investigated the relationship between apo-E genotypes and homocystein concentration in serum from hypertension patients.
Other employees you can reach at glaukos.com. View company contacts for 551 employees →
Tyler Brown
Colleague at Glaukos CorporationDana Point, California, United States
View →
LW
Luke Wuertemberger
Colleague at Glaukos CorporationChicago, Illinois, United States
View →
CR
Claudine Reider
Colleague at Glaukos CorporationSan Clemente, California, United States
View →
MK
Mary K.
Colleague at Glaukos CorporationChaska, Minnesota, United States
View →
CE
Calvin Earl Cortes
Colleague at Glaukos CorporationRancho Santa Margarita, California, United States
View →
GC
Gaby C.
Colleague at Glaukos CorporationMexico City, Mexico
View →
DR
Daniela Ruiz
Colleague at Glaukos CorporationIrvine, California, United States
View →
DO
Dara Oeun
Colleague at Glaukos CorporationLowell, Massachusetts, United States
View →
SG
Ståle Gyth (Staale Gyth)
Colleague at Glaukos CorporationKopervik, Rogaland, Norway
View →
LM
Linda Murray
Colleague at Glaukos CorporationMarlborough, Massachusetts, United States
View →
Dissertation: Analysis of allelic association between monoamine oxidase (MAO) and the level of MAO metabolite from human blood sample.
Activities and Societies: Relationship of plasmids and resistance of antibiotics in Staphylococcus aureus. Men's Volleyball Team
Quick answers generated from the profile data available on this page.
Jia-Ying John Y. works for Glaukos Corporation.
Jia-Ying John Y. is listed as Self-motivated scientist with extensive hand-on in-vivo experience at Glaukos Corporation.
AeroLeads has found 1 work email signal at @glaukos.com for Jia-Ying John Y. at Glaukos Corporation.
Jia-Ying John Y. is based in Irvine, California, United States while working with Glaukos Corporation.
Jia-Ying John Y. has worked for Glaukos Corporation, Allergan, Uc Irvine, University Of California, and Allergan Inc..
Jia-Ying John Y.'s colleagues at Glaukos Corporation include Tyler Brown, Luke Wuertemberger, Claudine Reider, Mary K., and Calvin Earl Cortes.
You can use AeroLeads to view verified contact signals for Jia-Ying John Y. at Glaukos Corporation, including work email, phone, and LinkedIn data when available.
Jia-Ying John Y. holds Ph.D, Experimental Pathology And Laboratory Medicine from Uc Irvine.
Jia-Ying John Y. is listed with skills including Screening, Cell Biology, In Vivo, Cap, Compound Screening, Macular Degeneration, Biotechnology, and Rna Isolation.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts